Cargando…
Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
Drug scheduling within the international system of drug control and national legislation has been recently criticized as having insufficient footing in scientific evidence. The legal harms related to non-medical uses of certain drugs (e.g., cannabis) have arguably exceeded their physiological and so...
Autor principal: | Dubljević, Veljko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109763/ https://www.ncbi.nlm.nih.gov/pubmed/30177880 http://dx.doi.org/10.3389/fphar.2018.00898 |
Ejemplares similares
-
Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022) -
The New Zealand drug harms ranking study: A multi-criteria decision analysis
por: Crossin, Rose, et al.
Publicado: (2023) -
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables
por: Tyson, Rachel J., et al.
Publicado: (2020) -
The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022) -
Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)